Niagen Bioscience, Inc. (NAGE)
6.36
-0.12
(-1.85%)
USD |
NASDAQ |
Dec 31, 16:00
6.36
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Market Cap: 507.57M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TransMedics Group, Inc. | 4.157B |
| Corcept Therapeutics, Inc. | 3.661B |
| Liquidia Corp. | 3.000B |
| Recursion Pharmaceuticals, Inc. | 2.129B |
| Caris Life Sciences, Inc. | 7.589B |
Market Cap Related Metrics
| PE Ratio | 26.14 |
| PS Ratio | 4.306 |
| PEG Ratio | 0.0221 |
| Price to Book Value | 7.182 |
| Price to Free Cash Flow | 25.46 |
| Price | 6.36 |
| Earnings Yield | 3.83% |
| PEGY Ratio | 0.0221 |
| Operating PE Ratio | 27.82 |
| Normalized PE Ratio | 26.13 |